Prognostic value of stress hyperglycemia for in-hospital outcome in acute coronary artery disease

Arquivos Brasileiros de Cardiologia

Volumn 100, Issue 2, 2013, Pages 127-133

  Pinheiro, Carlos Passos ^a   Oliveira, Marcos Danillo Peixoto ^a   Faro, Gustavo Baptista de Almeida ^a   Silva, Esdras Correa ^a   da Rocha, Eduardo Augusto Andrade ^a   Barreto Filho, José Augusto Soares ^a,b   Oliveira, Joselina Luzia Menezes ^a,b   Sousa, Antônio Carlos Sobral ^a,b  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b Hospital e Fundação São Lucas   (Brazil)

Author keywords

Hyperglycemia complications; Length of stay; Prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOPULMONARY ARREST; CEREBROVASCULAR ACCIDENT; DEATH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; ISCHEMIA; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RESPIRATORY FAILURE; THORAX PAIN;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; RISK FACTORS; SEX FACTORS;

EID: 84878211407     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20130025     Document Type: Article

References (34)

1. Nigro D, Serrano Jr CV, Souza JA. Considerações sobre o significado e o manuseio da intolerância a glicose em pacientes admitidos com síndrome coronária aguda. Rev Bras Hipertens. 2005;12(3):178-81.
2. Chacra AR, Alvarenga MA. Hiperglicemia e doença cardiovascular podem coexistir. Arq Bras Endrocrinol Metab. 2008;52(3):427-8.
3. Oliver MF. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med. 2002;112(4):305-11.
4. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324):2140-4.
5. Tenerz A, Lonnberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J. 2001;22(13):1102-10.
6. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl 2):S14-21.
7. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care. 2006:29(Suppl. 1):S4-42.
8. Alvarenga MA, Oliveira CS, Chacra AR, Reis AF. Avaliação cardiovascular de pacientes diabéticos em ambulatório universitário. Arq Bras Endocrinol Metab. 2007;51(2):281-4.
9. Schraan BD, Reis AF. Doença cardiovascular e diabetes. Arq Bras Endocrinol Metab. 2007;51(2):151-2.
10. Zecchin HG, Nadruz Junior W, Saad MJ. Importância e tratamento do diabete melito e da hiperglicemia no infarto agudo do miocárdio. Rev Soc Cardiol Estado de São Paulo. 2004;14(6):1017-30.
11. Lerario AC, Coretti FM, Oliveira SF, Betti RT, Bastos MS, Ferri LA, et al. Avaliação da prevalência do diabetes e da hiperglicemia de estresse no infarto agudo do miocárdio. Arq Bras Endocrinol Metab [online]. 2008;52(3):465-72.
12. Gois AF. Glicemia no prognóstico da síndrome coronariana aguda. Arq Bras Endocrinol Metab [online]. 2008;52(3):429-30.
13. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglicaemia and increased risk of death after myocardial infarction in patients with and without diabetes a systematic overview. Lancet. 2000;355(9206):773-8.
14. Timmer JR, van der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, et al; Zwolle Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004;148(3):399-404.
15. Cheung NW, Wong VW, McLean M. The Hyperglycemia Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29(4):765-70.
16. Nery PB, Bodanese LC, Manenti E. Valor prognóstico da resolução da elevação do segmento ST na reperfusão miocárdica. Arq Bras Cardiol. 2003;80(1):101-4.
17. Mion D Jr, Machado CA, Gomes MA, Nobre F, Kohlmann O Jr, Amodeo C, et al; Sociedade Brasileira de Cardiologia / Sociedade Brasileira de Hipertensão / Sociedade Brasileira de Nefrologia. IV Diretrizes brasileiras de hipertensão arterial. Arq Bras Cardiol. 2004;82(supl. 4):3-14.
18. Shisshehbor MH, Lauer MS, Singh IM, Chew DP, Karha J, Brener SJ, et al. In unstable angina or non-ST-segment acute coronary syndromes, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol. 2007;49(8):849-54.
19. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed). 1986;293(6552):917-22.
20. Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR. Diabetes and stress hyperglycemia with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev. 2005;13(5):223-30.
21. Norhammar AM, Rydèn L, Malmberg K. Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care. 1999;22(11):1827-31.
22. Duarte ER, Pellanda LC, Portal VL. Perfil inflamatório, metabólico e lipídico na síndrome isquêmica aguda: relação com eventos intra e pós-hospitalares. Arq Bras Cardiol. 2005;84(2):122-9.
23. Rocha S, Nabais S, Magalhaes S, Salgado A, Azevedo P, Marques J, et al. Glicemia na admissão: factor preditivo de morte após síndrome coronária aguda em doentes não diabéticos? Rev Port Cardiol. 2007;26(12):1367-77.
24. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med. 2006;166(15):1613-9.
25. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;164(9):9892-8.
26. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenström A, et al. Randomized trial of insulin glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (Digami Study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57-65.
27. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Eng J Med. 2001;345(19):1359-67.
28. Foo K, Cooper J, Deaner A, Knigh C, Suliman A, Ranjadoyalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndrome. Heart. 2003;89(5):512-6.
29. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: a independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-82.
30. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22(2):233-40.
31. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J. 2007;28(1):88-136.
32. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031-7.
33. Ceriello A. Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J. 2005;26(4):328-31.
34. Huoya M de O, Penalva RA, Alves SR, Feitosa GS, Gadelha S, Ladeia AM. Comparação de biomarcadores inflamatórios entre pacientes diabéticos e não-diabéticos com angina instável. Arq Bras Cardiol. 2009;92(4):283-9.